VIVIMEDLAB vs ZOTA: Stock Comparison

Vivimed Labs Limited vs Zota Health Care LtdUpdated 16 Apr 26, 4:01 PM ISTNSE & company filings

Zota Health Care Ltd is the larger company by market capitalisation. Vivimed Labs Limited shows a higher ROCE, while Zota Health Care Ltd shows a higher dividend yield, faster revenue growth and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

VIVIMEDLAB leads 2; ZOTA leads 4 of 7

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

VIVIMEDLABZOTA

Valuation lens

What price are you paying?

Market CapContext only
₹55 Cr
₹3,737 Cr
P/E RatioSame reading
-35.61x
P/B RatioSame reading
5.44x
EPSVIVIMEDLAB has the higher reading
₹-2.92
₹-30.6
Book ValueContext only
₹4.75
₹200
Dividend YieldZOTA has the higher reading
0%
0.09%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ZOTA is the larger company
₹3,737 Cr vs ₹55 Cr
EPS
VIVIMEDLAB has higher earnings per share
₹-2.92 vs ₹-30.6
Dividend Yield
ZOTA has a higher dividend yield
0.09% vs 0%
Revenue Growth (TTM YoY)
ZOTA has faster revenue growth
67.7% vs -22.42%
ROCE
VIVIMEDLAB has a higher ROCE
0% vs -8.47%
Net Margin
ZOTA has a higher net margin
-13.98% vs -27.09%
Operating Margin
ZOTA has a higher operating margin
0.49% vs -24.46%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricVIVIMEDLABZOTA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricVIVIMEDLABZOTA
Live Price₹7.39₹1,076.8
Day Change-3.15%-1.62%
Volume1.47 L1.1 L
52-Week High₹20.59₹1,740
52-Week Low₹5.15₹1,026.2
Distance from 52W High-64.11%-38.11%

Valuation

MetricVIVIMEDLABZOTA
Market Cap₹55 Cr₹3,737 Cr
P/E Ratio-35.61x
P/B Ratio5.44x
EPS₹-2.92₹-30.6
Book Value₹4.75₹200
Dividend Yield0%0.09%

Growth

MetricVIVIMEDLABZOTA
Revenue Growth (TTM YoY)-22.42%67.7%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth67.6%
Qtr Profit Growth-204%

Profitability & Leverage

MetricVIVIMEDLABZOTA
ROE-15%
ROCE0%-8.47%
Net Margin-27.09%-13.98%
Operating Margin-24.46%0.49%
Debt to Equity0.39x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricVIVIMEDLABZOTA
Promoter Holding7.57% 0.2 pp49.38%
FII Holding1.64%7.92% 0.29 pp
DII Holding0%6.75% 0.35 pp
Public Holding90.67% 0.19 pp35.96% 0.04 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Vivimed Labs Limited and Zota Health Care Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.